MassMutual Private Wealth & Trust’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
MassMutual Private Wealth & Trust's CORT Position: Q3 2026 in Review
MassMutual Private Wealth & Trust increased its Corcept Therapeutics (CORT) stake by 4.2% in Q3 2026, buying an estimated $1.94K and bringing the position to 450 shares worth $51.9K. The position accounts for ﹤0.01% of the portfolio, ranked #730.
MassMutual Private Wealth & Trust first reported a position in CORT in Q1 2018 and has held it in 18 quarters since. The position peaked at $140K in Q4 2023. 280 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- MassMutual Private Wealth & Trust held 450 shares of Corcept Therapeutics worth $51.9K as of Q3 2026.
- MassMutual Private Wealth & Trust bought 18 Corcept Therapeutics shares in Q3 2026, an estimated $1.94K.
- Corcept Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #730 holding.
- MassMutual Private Wealth & Trust first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 18 quarters since.
- MassMutual Private Wealth & Trust's Corcept Therapeutics position peaked at $140K in Q4 2023.
- 280 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.